These findings suggest that, although the EGF-stimulated endocytic degradation of wild-type EGFR is rapid in certain cell types, this process of wild-type protein could also happen more slowly compared to the EGF-induced downregulation of mutated EGFR in some other NSCLC cell systems. Here, EGFR is linked to non-small cell lung carcinoma.